International Urology and Nephrology

, Volume 44, Issue 2, pp 635–638 | Cite as

A novel link: in children, cow milk processing may be causative of idiopathic membranous nephropathy

  • Michael Haase
  • Anja Haase-Fielitz
  • Peter R. Mertens
Nephrology – Translational Section


  1. 1.
    Debiec H, Lefeu F, Kemper M et al (2011) Early-childhood membranous nephropathy due to cationic bovine serum albumin. NEJM 364:2101–2110PubMedCrossRefGoogle Scholar
  2. 2.
    Fervenza FC, Sethi S, Specks U (2008) Idiopathic membranous nephropathy: diagnosis and treatment. Clin J Am Soc Nephrol 3:905–919PubMedCrossRefGoogle Scholar
  3. 3.
    O’Callaghan CA, Hicks J, Doll H et al (2002) Characteristics and outcome of membranous nephropathy in older patients. Int Urol Nephrol 33:157–165PubMedCrossRefGoogle Scholar
  4. 4.
    Zaffanello M, Franchini M (2007) Thromboembolism in childhood nephrotic syndrome: a rare but serious complication. Hematology 12:69–73PubMedCrossRefGoogle Scholar
  5. 5.
    Branten AJ, du Buf-Vereijken PW, Klasen IS et al (2005) Urinary excretion of beta2-microglobulin and IgG predict prognosis in idiopathic membranous nephropathy: a validation study. J Am Soc Nephrol 16:169–174PubMedCrossRefGoogle Scholar
  6. 6.
    Mohácsi G, Magori A, Sonkodi S (1988) Long-term effects of steroid and cytostatic treatment on the clinical course of idiopathic membranous glomerulonephritis (retrospective study). Int Urol Nephrol 20:315–325PubMedCrossRefGoogle Scholar
  7. 7.
    Cravedi P, Sghirlanzoni MC, Marasà M et al (2011) Efficacy and safety of rituximab second-line therapy for membranous nephropathy: a prospective, matched-cohort study. Am J Nephrol 33:461–468PubMedCrossRefGoogle Scholar
  8. 8.
    Beck LH Jr, Fervenza FC, Beck DM et al (2011) Rituximab-induced depletion of anti-PLA2R autoantibodies predicts response in membranous nephropathy. J Am Soc Nephrol 22:1543–1550PubMedCrossRefGoogle Scholar
  9. 9.
    Fervenza FC, Abraham RS, Erickson SB et al (2010) Rituximab therapy in idiopathic membranous nephropathy: a 2-year study. Clin J Am Soc Nephrol 5:2188–2198PubMedCrossRefGoogle Scholar
  10. 10.
    McGrogan A, Franssen CF, de Vries CS (2011) The incidence of primary glomerulonephritis worldwide: a systematic review of the literature. Nephrol Dial Transplant 26:414–430PubMedCrossRefGoogle Scholar
  11. 11.
    Filler G, Young E, Geier P et al (2003) Is there really an increase in non-minimal change nephrotic syndrome in children? Am J Kidney Dis 42:1107–1113PubMedCrossRefGoogle Scholar
  12. 12.
    Chen A, Frank R, Vento S et al (2007) Idiopathic membranous nephropathy in pediatric patients: presentation, response to therapy, and long-term outcome. BMC Nephrol 8:11PubMedCrossRefGoogle Scholar
  13. 13.
    Jones DB (1957) Nephrotic glomerulonephritis. Am J Pathol 33:313–329PubMedGoogle Scholar
  14. 14.
    Beck LH Jr, Bonegio RG, Lambeau G et al (2009) M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy. N Engl J Med 361:11–21PubMedCrossRefGoogle Scholar
  15. 15.
    Debiec H, Ronco P (2011) PLA2R autoantibodies and PLA2R glomerular deposits in membranous nephropathy. N Engl J Med 364:689–690PubMedCrossRefGoogle Scholar
  16. 16.
    Debiec H, Guigonis V, Mougenot B et al (2002) Antenatal membranous glomerulonephritis due to anti-neutral endopeptidase antibodies. N Engl J Med 346:2053–2060PubMedCrossRefGoogle Scholar
  17. 17.
    Chen JS, Chen A, Chang LC et al (2004) Mouse model of membranous nephropathy induced by cationic bovine serum albumin: antigen dose-response relations and strain differences. Nephrol Dial Transplant 19:2721–2728PubMedCrossRefGoogle Scholar
  18. 18.
    Border WA, Ward HJ, Kamil ES et al (1982) Induction of membranous nephropathy in rabbits by administration of an exogenous cationic antigen. J Clin Invest 69:451–461PubMedCrossRefGoogle Scholar
  19. 19.
    Yamamoto T, Miyazaki S, Kawasaki K et al (1986) Rat bovine serum albumin (BSA) nephritis. VI. The influence of chemically altered antigen. Clin Exp Immunol 65:51–56PubMedGoogle Scholar
  20. 20.
    Wu CC, Chen JS, Huang CF et al (2011) Approaching biomarkers of membranous nephropathy from a murine model to human disease. J Biomed Biotechnol 2011:581928PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, B.V. 2011

Authors and Affiliations

  • Michael Haase
    • 1
  • Anja Haase-Fielitz
    • 1
  • Peter R. Mertens
    • 1
  1. 1.Department of Nephrology and Hypertension, Diabetes and EndocrinologyOtto von Guericke University MagdeburgMagdeburgGermany

Personalised recommendations